Amira Pharma Raises $25 Million

Amira Pharmaceuticals Inc., a San Diego-based drug company focused on imflammatory diseases, has raised $25 million in Series B funding. Novo AS led the deal, and was joined by return backers Avalon Ventures, Prospect Venture Partners and Versant Ventures. www.amirapharm.com